Sponsors

Do you wish to display your services and expertise at this exclusive event

If you want to be part of this industry forum, please contact

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry.  Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically.  For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and added-value services to meet the rapidly changing technology requirements of the industry it serves.  Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of “Turning science into solutions.”
www.sartorius.com

ATMI LifeSciences strives to be the source of process efficiency to its biopharmaceutical customers, providing a broad range of proprietary disposable storage, mixing and bioreactor technology solutions that maximize product integrity while optimizing manufacturing cost.

With the recent acquisition of Levtech, Inc., a market-leading provider of disposable mixing technologies to the biopharma industry, ATMI LifeSciences is further extending its disposable technologies market leadership.

The NewformTM product line supplies ultraclean sterilizable flexible packaging for advanced purity components and active ingredients.

The Newmix® product line supplies scalable disposable mixing and storage technologies.

The NewsafeTM product line proposes disposable containment systems.
Nucleo, the next generation single-use bioreactor, is a complete disposable solution for a wide range of cell culture applications, co-developed with Pierre Guérin-Biolafitte and Artelis.

For more information, please visit atmi-lifesciences.com

CMC Biopharmaceuticals - a Center of Bio-manufacturing Excellence for the production of therapeutic biologics (including antibodies, cytokines, recombinant proteins etc).

• Fully compliant with FDA and EMEA regulations
• Phase I, II, III clinical trial and commercial supply
• Facilities in Europe and US
• Both microbial fermentation and mammalian cell culture processes
• 100-L to 3,000-L batch size; highly flexible cGMP facilities
• Stirred tank and perfusion process technologies
• Commitment to excellent customer service and project management

Pall’s leading edge filtration, separation, purification technologies and services play an essential and pivotal role in the life sciences industry.
In Biopharmaceuticals, Pall filtration, chromatography, sampling, monitoring and quality assurance products, together with technical services in validation, assays and process optimization are applicable to laboratory and pilot-scale development, aseptic processing, biologicals, bioprocessing, fermentation and downstream processing.

www.pall.com/biopharm